Company / Interest Expense per Share
Gossamer Bio, Inc. Interest Expense per Share History
FY2018-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.09
FY2023
5-year range
$0.09 / $0.26
FY2019-FY2023
Trend
-46.1%
vs FY2022
Sector context
#26 of 43
Health Care
What the data says
At $0.09, Gossamer Bio, Inc.'s interest expense per share ranks #18 of 43 in the Health Care sector. Improved from $0.26 to $0.09 over the past 2 years.
Based on SEC 10-K filings.
0.09 in FY2023 with a 5-year CAGR of +116.9%.
Improved from $0.26 to $0.09 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -21.8%
- 5-Year CAGR
- +116.9%
- 10-Year CAGR
- -
Sector benchmark
#18 of 43 in Health CareTop 40% of 43This company $0.09 Sector average $18.61
▼
-99.5% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share decreased 46.1% year-over-year.
- Ranks #26 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2021.
- Lowest interest expense per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -9.62 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.09 | -46.1% |
| FY2022 | $0.16 | -36.8% |
| FY2021 | $0.26 | +40.5% |
| FY2020 | $0.18 | +422.2% |
| FY2019 | $0.04 | +1819.1% |
| FY2018 | $0.00 | - |
| FY2017 | - | - |
As of FY2023 · SEC 10-K · Updated Mar 28, 2026